NCT00477555

Brief Summary

The special fixation methodology of the Mosaic Ultra stented procine bioprosthesis allows valves to maintain their natural leaflet structure and root geometry which prevents leaflet calcification and improves hemodynamic performance and a potential for increased durability. This study will document the hemodynamic performance, as assessed by echocardiographic recordings, at six months post implantation.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2006

Longer than P75 for all trials

Geographic Reach
5 countries

11 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2006

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 21, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 23, 2007

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2010

Completed
Last Updated

October 29, 2015

Status Verified

October 1, 2015

Enrollment Period

3.8 years

First QC Date

May 21, 2007

Last Update Submit

October 28, 2015

Conditions

Keywords

aortic valveconcomitant proceduresporcine bioprosthesisstented valve

Interventions

All patients get implanted with a Mosaic Ultra tissue valve to evaluate hemodynamic performance at 6 months post implant.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who are eligible for an aortic valve replacement can be enrolled in the study.

You may qualify if:

  • Patients who require aortic valve replacement with or without coronary artery bypass grafting or surgical treatment of Atrial Fibrillation.
  • Patients who are able to provide informed consent.

You may not qualify if:

  • Concomitant procedures other than coronary artery bypass grafting or surgical treatment of Atrial Fibrillation.
  • Patients indicated for receiving a mechanical prosthesis.
  • Patients who will have a replacement of an existing valve prosthesis.
  • Patients refusing or not able to provide informed consent.
  • Patients requiring emergency surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Medinische Universitat Innsbruck

Innsbruck, A-6020, Austria

Location

ZNA Middelheim

Antwerp, Antwerp, 2020, Belgium

Location

Imelda Ziekenhuis

Bonheiden, 2820, Belgium

Location

Hopital St Luc

Bouge, 5004, Belgium

Location

Klinik fur Thorax- Herz und Gefasschirurgie

Dortmund, 44139, Germany

Location

Klinikum der Johann-Wolfgang-Goethe Universitat

Frankfurt Am Mein, 60590, Germany

Location

Albertinen Krankenhaus

Hamburg, 22457, Germany

Location

Soroka University Medical Center

Beersheba, 84101, Israel

Location

Rambam Medical Center

Haifa, 31096, Israel

Location

Hadasit Medical Research Services

Jerusalem, 91120, Israel

Location

U.O. Cardiochirurgia del p.p. Civico

Palermo, 90127, Italy

Location

Study Officials

  • Jaak Minten, PhD

    Clinical Director Cardiac Surgery Medtronic

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2007

First Posted

May 23, 2007

Study Start

April 1, 2006

Primary Completion

February 1, 2010

Study Completion

February 1, 2010

Last Updated

October 29, 2015

Record last verified: 2015-10

Locations